一、SCI文章90篇

1.       Qin Q, Qu J, Yin Y, Liang Y, Wang Y, Xie B, Liu Q, Wang X, Xia X, Wang M, Zhang X, Jia J, Xing Y*, Li C*, Tang Y*. Unsupervised machine learning model to predict cognitive impairment in subcortical ischemic vascular disease. Alzheimers Dement. 2023 Feb 14. doi: 10.1002/alz.12971.

2.       Qin Q, Wang M, Li H*, Xu ZD*, Tang Y*. Editorial: The role of microglia in the pathogenesis of neurodegenerative diseases. Front Aging Neurosci. 2023 Jan 6;14:1105896. doi: 10.3389/fnagi.2022.1105896. 

3.       Liu PP, Dai SK, Mi TW, Tang GB, Wang Z, Wang H, Du HZ, Tang Y*, Teng Z*, Liu CM*.. Acetate supplementation restores cognitive deficits caused by ARID1A haploinsufficiency in excitatory neurons. EMBO Mol Med. 2022;e15795. doi:10.15252/emmm.202215795.

4.       Yu CJ, Wang M, Li RY, Wei T, Yang HC, Yin YS, Mi YX, Qin Q, Tang Y*. TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology. Mol Neurobiol. 2023 Feb;60(2):512-523. doi: 10.1007/s12035-022-03100-1.

5.       Xia X, Qin Q, Peng Y, Wang M, Yin Y, Tang Y*. Retinal Examinations Provides Early Warning of Alzheimer's Disease. J Alzheimers Dis. 2022;10.3233/JAD-220596. doi: 10.3233/JAD-220596.

6.       Shi X, Wei T, Hu Y, Wang M, Tang Y*. The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study. J Neuroinflammation. 2022 Sep 6;19(1):218. doi: 10.1186/s12974-022-02582-z.

7.       Lutz MW, Khachaturian AS, Zetterberg H, Blennow K, Willette AA, Mielke MM, Hayden KM, Dodge HH, Tang Y, Greenberg BD, Kukull WA, Khachaturian ZS. Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide. Alzheimers Dement. 2022 Sep;18(9):1595-1601. doi: 10.1002/alz.12772.

8.       Zhang SF, Dai SK, Du HZ, Wang H, Li XG, Tang Y*, Liu CM*. The epigenetic state of EED-Gli3-Gli1 regulatory axis controls embryonic cortical neurogenesis. Stem Cell Reports. 2022 Sep 13;17(9):2064-2080. doi: 10.1016/j.stemcr.2022.07.004.

9.       Yu Y, Lu Y, Wang F, Lu Y, Xie B, Meng X, Tang Y*. Acanthocytes Identified in Huntington's Disease. Front Neurosci. 2022 Jun 6; 16:913401. doi: 10.3389/fnins.2022.913401.

10.    Qin Q, Wang M, Yin Y, Tang Y*. The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer's Disease. Front Immunol. 2022 May 19; 13:845897. doi: 10.3389/fimmu.2022.845897.

11.    Wang YY, Deng YS, Dai SK, Mi TW, Li RY, Liu PP, Liu C, HeBD, He XC, Du HZ, Yang HC, Tang Y*, Liu CM*, Teng ZQ*. Loss of microglial EED impairs synapse density, learning and memory. Mol Psychiatry. 2022 Jul; 27(7):2999-3009. doi: 10.1038/s41380-022-01576-w.

12.    Li RY, Qin Q, Yang HC, Wang YY, Mi YX, Yin YS, Wang M, Yu CJ, Tang Y*. TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target. Mol Neurodegener. 2022 Jun 3;17(1):40. doi: 10.1186/s13024-022-00542-y.

13.    Wei T, Guo Z, Wang Z, Li C, Zhu W, Zheng Y, Yin Y, Mi Y, Xia X, Hou H, Tang Y*. Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study. J Alzheimers Dis. 2022 Mar 31. doi: 10.3233/JAD-220010.

14.    Mi Y, Qin Q, Xing Y, Tang Y*. Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer's Disease. J Alzheimers Dis. 2022 Mar 2. doi: 10.3233/JAD-215565.

15.    Temp AGM, Ly A, van Doorn J, Wagenmakers EJ, Tang Y, Lutz MW, Teipel S. A Bayesian perspective on Biogen's aducanumab trial. Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12615.

16.    Shenoy SA, Zheng S, Liu W, Dai Y, Liu Y, Hou Z, Mori S, Tang Y, Cheng J, Duan W, Li C. A novel and accurate full-length HTT mouse model for Huntington's disease. Elife. 2022 Jan 13;11:e70217. doi: 10.7554/eLife.70217.

17.    Teipel S, Gustafson D, Ossenkoppele R, Hansson O, Babiloni C, Wagner M, Riedel-Heller S, Kilimann I, Tang Y. Alzheimer's disease - standard of diagnosis, treatment, care, and prevention. J Nucl Med. 2022 Feb 10:jnumed.121.262239. doi: 10.2967/jnumed.121.262239.

18.    Qin Q, Yin Y, Xing Y, Wang X, Wang Y, Wang F, Tang Y*. Lipid Metabolism in the Development and Progression of Vascular Cognitive Impairment: A Systematic Review. Front Neurol. 2021 Nov 19;12:709134. doi: 10.3389/fneur.2021.709134.

19.    Xing Y, Yang J, Zhou A, Wang F, Tang Y*, Jia J*. Altered brain activity mediates the relationship between white matter hyperintensity severity and cognition in older adults. Brain Imaging Behav. 2022 Apr;16(2):899-908.

20.    Wang C#, Wang Z#, Xie B, Shi X, Yang P, Liu L, Qu T, Qin Q, Xing Y, Zhu W, Teipel SJ, Jia J, Zhao G*, Li L*, Tang Y*. Binaural processing deficit and cognitive impairment in Alzheimer’s disease. Alzheimers Dement. 2021, DOI: 10.1002/alz.12464.

21.    Wang Z, Zhu W, Xing Y, Jia J, Tang Y*. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis. Nutr Rev. 2022 Mar 10;80(4):931-949.

22.    Temp AGM, Lutz MW, Trepel D, Tang Y, Wagenmakers EJ, Khachaturian AS, Teipel S. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease. Alzheimers Dement. 2021 Jun;17(6):917-919.

23.    Xing Y, Yang J, Zhou A, Wang F, Wei C, Tang Y*, Jia J*. White Matter Fractional Anisotropy Is a Superior Predictor for Cognitive Impairment Than Brain Volumes in Older Adults With Confluent White Matter Hyperintensities. Front Psychiatry. 2021, 5;12:633811. doi: 10.3389/fpsyt.2021.633811. eCollection 2021.

24.    Wang F, Ma X, Shi Y, Jia L, Zuo X, Yu Y, Jin H, Tang Y, Guo D, Jia J. Cognitive profiles in adult-onset neuronal intranuclear inclusion disease: a case series from the memory clinic. Neurol Sci. 2020; doi: 10.1007/s10072-020-04864-x.

25.    Wang Z, Yang J, Zhu W, Tang Y*, Jia J. The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis. Int J Neurosci. 2021; 10:1-9. doi: 10.1080/00207454.2021.1881087.

26.    Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Y*. TREM2, microglia, and Alzheimer's disease. Mech Ageing Dev. 2021;195:111438.

27.    Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, Song Y, Shi Y, Zhang H, Gong M, Wei C, Tang Y, Fang B, Guo D, Wang F, Zhou A, Chu C, Zuo X, Yu Y, Yuan Q, Wang W, Li F, Shi S, Yang H, Zhou C, Liao Z, Lv Y, Li Y, Kan M, Zhao H, Wang S, Yang S, Li H, Liu Z, Wang Q, Qin W, Jia J; COAST Group. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661-e671.

28.    Jia L, Li F, Wei C, Zhu M, Qu Q, Qin W, Tang Y, Shen L, Wang Y, Shen L, Li H, Peng D, Tan L, Luo B, Guo Q, Tang M, Du Y, Zhang J, Zhang J, Lyu J, Li Y, Zhou A, Wang F, Chu C, Song H, Wu L, Zuo X, Han Y, Liang J, Wang Q, Jin H, Wang W, Lü Y, Li F, Zhou Y, Zhang W, Liao Z, Qiu Q, Li Y, Kong C, Li Y, Jiao H, Lu J, Jia J. Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study. Brain. 2020. doi: 10.1093/brain/awaa364.

29.    Sikkes SAM, Tang Y, Jutten RJ, Wesselman LMP, Turkstra LS, Brodaty H, Clare L, Cassidy-Eagle E, Cox KL, Chételat G, Dautricourt S, Dhana K, Dodge H, Dröes RM, Hampstead BM, Holland T, Lampit A, Laver K, Lutz A, Lautenschlager NT, McCurry SM, Meiland FJM, Morris MC, Mueller KD, Peters R, Ridel G, Spector A, van der Steen JT, Tamplin J, Thompson Z; ISTAART Non-pharmacological Interventions Professional Interest Area, Bahar-Fuchs A. Toward a theory-based specification of non-pharmacological treatments in aging and dementia: Focused reviews and methodological recommendations. Alzheimers Dement. 2021;17(2):255-270.

30.    Jia L, Xu H, Chen S, Wang X, Yang J, Gong M, Wei C, Tang Y, Qu Q, Chu L, Shen L, Zhou C, Wang Q, Zhao T, Zhou A, Li Y, Li F, Li Y, Jin H, Qin Q, Jiao H, Li Y, Zhang H, Lyu D, Shi Y, Song Y, Jia J*. The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease. Alzheimers Dement. 2020. doi: 10.1002/alz.12153.

31.    Tang Y*, Xing Y, Cui L, Wu C, Wen X, Song H, Wu L, Chang H, Song J, Wang Y*, Zhao G*. Neurology practice during the COVID-19 outbreak and post-pandemic era: experiences and challenges. Eur J Neurol. 2020 Jul 17:10.1111/ene.14445. doi: 10.1111/ene.14445.

32.    Jia L, Zhu M, Kong C, Pang Y, Zhang H, Qiu Q, Wei C, Tang Y, Wang Q, Li Y, Li T, Li F, Wang Q, Li Y, Wei Y, Jia J. Blood neuro-exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage. Alzheimers Dement. 2021;17(1):49-60.

33.    Qin Q, Yin Y, Wang Y, Lu Y, Tang Y*, Jia J*. Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status. Mol Genet Genomic Med. 2020 Aug 6:e1443. doi: 10.1002/mgg3.1443.

34.    Xing Y, Zhu Z, Du Y, Zhang J, Qu Q, Sun L, Li Y, Guo Y, Peng G, Liu Y, Yu Y, Qiao Y, Xie B, Shi X, Lu J, Jia J, Tang Y*. The Efficacy of COGnitive tRaining in patiEnts with Amnestic mild coGnitive impairmENT (COG-REAGENT): Protocol for a Multi-Center Randomized Controlled Trial. J Alzheimers Dis. 2020;75(3):779-787.

35.    Xing Y, Wei P, Wang C, Shan Y, Yu Y, Qiao Y, Xie B, Shi X, Zhu Z, Lu J, Zhao G, Jia J, Tang Y*. TRanscranial AlterNating current Stimulation FOR patients with Mild Alzheimer's Disease (TRANSFORM-AD study): Protocol for a randomized controlled clinical trial. Alzheimers Dement (N Y). 2020;6(1):e12005.

36.    Xie B, Shi X, Xing Y, Tang Y*. Association between atherosclerosis and Alzheimer's disease: A systematic review and meta-analysis. Brain Behav. 2020;10(4):e01601.

37.    Qin Q, Tang Y*, Dou X, Qu Y, Xing Y, Yang J, Chu T, Liu Y, Jia J. Default mode network integrity changes contribute to cognitive deficits in subcortical vascular cognitive impairment, no dementia. Brain Imaging Behav. 2021;15(1):255-265.

38.    Jia J*, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L. Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease. J Alzheimers Dis. 2020. doi: 10.3233/JAD-190940.

39.    Jia L, Fu Y, Shen L, Zhang H, Zhu M, Qiu Q, Wang Q, Yan X, Kong C, Hao J, Wei C, Tang Y, Qin W, Li Y, Wang F, Guo D, Zhou A, Zuo X, Yu Y, Li D, Zhao L, Jin H, Jia J*. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease. Alzheimers Dement. 2020;16(1):178-191.

40.    Tang Y*, Liu Y, Li D, Guo D, Xing Y*. A novel mutation in the CYP27A1 gene in a family with cerebrotendinous xanthomatosis. Int J Neurosci. 2020; 1-4.

41.    Quan M, Zhao T, Tang Y, Luo P, Wang W, Qin Q, Li T, Wang Q, Fang J, Jia J*. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease. Alzheimers Res Ther. 2020;12(1):14.

42.    Wang H, Fan Z, Shi C, Xiong L, Zhang H, Li T, Sun Y, Guo Q, Tian Y, Qu Q, Zhang N, Cheng Z, Wu L, Wu D, Han Z, Tian J, Xie H, Tan S, Gao J, Luo B, Pan X, Peng G, Qin B, Tang Y, Wang K, Wang T, Zhang J, Zhao Q, Gauthier S, Yu X*. Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project. Journal of global health. 2019; 9(2): 020320

43.    Shi X, Xie B, Xing Y, Tang Y*. Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis. Curr Alzheimer Res. 2019;16(11):1018-1027.

44.    Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, Tang Y, Qin Q, Wang F, Qiao Y, Shi S, Wang YJ, Du Y, Zhang J, Zhang J, Luo B, Qu Q, Zhou C, Gauthier S, Jia J*; Group for the Project of Dementia Situation in China. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020 Jan;19(1):81-92.

45.    Shen L, Qin W, Wu L, Zhou A, Tang Y, Wang Q, Jia L, Jia J*. Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization. Biochem Biophys Res Commun. 2019;516(1):264-269.

46.    Tang Y#*, Xing Y#, Zhu Z#, He Y, Li F, Yang J, Liu Q, Li F, Teipel SJ, Zhao G*, Jia J*. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomized controlled trial. Alzheimers Dement. 2019;15(5):605-614.

47.    Liu Z*, Jiao L, Qiu Z, Da Y, Tang Y, Lin Y, Li D, Huang J, Kang X, Dong H*. Clinical characteristics of patients with paraneoplastic myelopathy.  J Neuroimmunol. 2019 ;330:136-142.

48.    Tang Y*, Qin Q*, Xing Y, Guo D, Di L, Jia J. AARS2 leukoencephalopathy: a new variant of mitochondrial encephalomyopathy. Mol Genet Genomic Med. 2019; 7(4):e00582.

49.    Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O'Bryant SE*; International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need. Alzheimers Dement. 2019;15(2):292-312.

50.    Du X#, Ji Y#, Chen T*, Tang Y, Han B. Can working memory capacity be expanded by boosting working memory updating efficiency in older adults? Psychology and Aging. 2018;33(8):1134-1151. (IF 2.608)

51.    Jia J*, Wei C, Chen S, Li F, Tang Y, Qin W, Shi L, Gong M, Xu H, Li F, He J, Song H, Yang S, Zhou A, Wang F, Zuo X, Chu C, Liang J, Jia L, Gauthier S. Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular dementia: A randomized clinical trial. Alzheimers Dement (N Y): TRCI. 2018; 4:108-117.

52.    Tang Y*, Lutz MW, Xing Y. A systems-based model of Alzheimer's disease. Alzheimers Dement. 2019;15(1):168-171.

53.    Hayden KM*, Inouye SK, Cunningham C, Jones RN, Avidan MS, Davis D, Kuchel GA, Tang Y, Khachaturian AS. Reduce the burden of dementia now. Alzheimers Dement. 2018;14(7):845-847.

54.    Khachaturian AS*, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gold M, Kukull WA, Mohs R, Gauthier S, Molinuevo JL, Zetterberg H, Khachaturian ZS. New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. Alzheimers Dement. 2018;14(6):703-706.

55.    Li J, Wu L, Tang Y, Zhou A, Wang F, Xing Y, Jia J*. Differentiation of neuropsychological features between posterior cortical atrophy and early onset Alzheimer's disease. BMC Neurol. 2018;18(1):65.

56.    Khachaturian AS#*, Hayden KM, Mielke MM, Tang Y, Lutz MW, Gustafson DR, Kukull WA, Mohs R, Khachaturian ZS. Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement. 2018;14(4):532-534.

57.    Wang Z, Qin W, Wei CB, Tang Y, Zhao LN, Jin HM, Li Y, Wang Q, Luan XQ, He JC, Jia J*. The microRNA-1908 up-regulation in the peripheral blood cells impairs amyloid clearance by targeting ApoE. Int J Geriatr Psychiatry. 2018;33(7):980-986.

58.    Jia J#*, Wei C*, Chen S, Li F, Tang Y, Qin W, Zhao L, Jin H, Xu H, Wang F, Zhou A, Zuo X, Wu L, Han Y, Han Y, Huang L, Wang Q, Li D, Chu C, Shi L, Gong M, Du Y, Zhang J, Zhang J, Zhou C, Lv J, Lv Y, Xie H, Ji Y, Li F, Yu E, Luo B, Wang Y, Yang S, Qu Q, Guo Q, Liang F, Zhang J, Tan L, Shen L, Zhang K, Zhang J, Peng D, Tang M, Lv P, Fang B, Chu L, Jia L, Gauthier S. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483-491

59.    Zhang Y, Guo D, Tang Y*. Autonomic dysfunction in a patient with X-linked adrenoleukodystrophy. Int J Neurosci.  2017; 28:1-2

60.    Liu Q#, Zhu Z#, Teipel SJ, Yang J, Xing Y, Tang Y*, Jia J* White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia. Front. Aging Neurosci. 2017; 9: 47.

61.    Jia J#*, Gauthier S, Pallotta S, Ji Y, Wei W, Xiao S, Peng D, Guo Q, Wu L, Chen S, Kuang W, Zhang J, Wei C, Tang Y. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease. Alzheimers Dement. 2017;13(5):592-597.

62.    Dong J, Qin W, Wei C, Tang Y, Wang Q, Jia J*. A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation.  J Alzheimers Dis. 2017;57(2):613-623.

63.    Jia J#*, Wei C#, Jia L, Tang Y, Liang J, Zhou A, Li F, Shi L, Doody RS. Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial. J Alzheimers Dis. 2017;56(4):1495-1504.

64.    Xing Y#, Tang Y#, Zhao L, Wang Q, Qin W, Ji X, Zhang J, Jia J*. Associations between plasma ceramides and cognitive and neuropsychiatric manifestations in Parkinson's disease dementia. J Neurol Sci. 2016;370:82-87.

65.    Tang Y#*, Zhu Z#, Liu Q, Li F, Yang J, Li F, Xing Y, Jia J*. The efficacy of Cognitive training in patients with VAsCular Cognitive Impairment, No dEmentia (the Cog-VACCINE study): study protocol for a randomized controlled trial. Trials. 2016;17(1):392.

66.    Xing Y#, Tang Y#, Zhao L, Wang Q, Qin W, Zhang J, Jia J*. Plasma ceramides and neuropsychiatric symptoms of Alzheimer’s disease. J Alzheimers Dis. 2016; 52(3):1029-35.

67.    Jia J*, Zuo X, Jia XF, Chu C, Wu L, Zhou A, Wei C, Tang Y, Li D, Qin W, Song H, Ma Q, Li J, Sun Y, Min B, Xue S, Xu E, Yuan Q, Wang M, Huang X, Fan C, Liu J, Ren Y, Jia Q, Wang Q, Jiao L, Xing Y, Wu X; China Cognition and Aging Study (COAST) Group. Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimers Dement. 2016; 12(4):446-53.

68.    Xing Y, Tang Y, Jia J*. Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status. Behav Neurol. 2015;2015:275256. doi: 10.1155/2015/275256.

69.    Tang Y*#, Wang X#, Jia J#. Mercury poisoning presenting as sporadic creutzfeldt-jakob disease: a case report. Ann Intern Med. 2015;162(6):462-3.

70.    Lu H, Wang XB, Tang Y*. Subdural hematoma associated with high altitude. Chin Med J (Engl). 2015;128(3):407-8.

71.    Qin W, Jia X, Wang F, Zuo X, Wu L, Zhou A, Li D, Min B, Wei C, Tang Y, Xing Y, Dong X, Wang Q, Gao Y, Li Y, Jia J*. Elevated plasma angiogenesis factors in Alzheimer's disease. J Alzheimers Dis. 2015;45(1):245-52.

72.    Liang J, Li F, Wei C, Song H, Wu L, Tang Y, Jia J*. Rationale and Design of a Multicenter, Phase 2 Clinical Trial to Investigate the Efficacy of Traditional Chinese Medicine SaiLuoTong in Vascular Dementia. J Stroke Cerebrovasc Dis. 2014; 23(10):2626-34.

73.    Jia J*, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439-47.

74.    Jia J*, Wang F, Wei C, Zhou A, Jia X, Li F, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 2014;10(1):1-9

75.    Jia J*, Wang F, Yuan Q, Qin W, Tang Y, Zuo XM, Han Y. Progresses on Genetics of Predementia Phase of Alzheimer's Disease. Prog Biochem Biophys. 2012;39(8), 698-702.

76.    Xing Y, Wei C, Chu C, Zhou A, Li F, Wu L, Song H, Zuo X, Wang F, Qin W, Li D, Tang Y, Jia XF, Jia J*. Stage-specific gender differences in cognitive and neuropsychiatric manifestations of vascular dementia. Am J Alzheimers Dis Other Demen. 2012;27(6):433-8.

77.    Tang Y#, Xing Y#, Lin MT, Zhang J, Jia J*. Hashimoto's encephalopathy cases: Chinese experience. BMC Neurol. 2012; 24;12:60.

78.    Dong HQ#, Liu Z#, Tang Y, Lu Y, Wang Q, Jia J*. Recurrent Fisher-Bickerstaff syndrome: report of a Chinese case. Chin Med J (Engl). 2011;124(17):2786-8.

79.    Tang Y#, Chu C#, Lin MT, Wei G, Zhang X, Da Y, Huang H, Jia J*. Hashimoto's encephalopathy mimicking spinocerebellar ataxia. J Neurol. 2011;258(9):1705-7.

80.    Huang H#*, Chen J, Lin T, Wang T, Tang Y, Dong Y, Wang J. Epoxyeicosatrienoic acids--novel mechanism and pharmacological therapy of chronic renocardiac syndrome. Med Hypotheses. 2011;76(4):550-2.

81.    Tang Y, Ding Y, Li CJ, Wang XB*, Jia J. longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease. J Neurol Neurosurg Psychiatry 2010;81:941-942

82.    Xu EH#, Tang Y, Li D, Jia J*. Polymorphism of HD and UCHL-1 genes in Huntington's disease. J Clin Neurosci. 2009, 16(11):1473-7.

83.    Li Y#, Liu W#, Oo TF, Wang L, Tang Y, Jackson-Lewis V, Zhou C, Geghman K, Bogdanov M, Przedborski S, Beal MF, Burke RE, Li C*. Mutant hR1441G LRRK2 BAC Transgenic Mice Recapitulate Cardinal Features of Parkinson’s Disease. Nature Neuroscience 2009, 12(7):826-8.

84.    Tang Y#, Huang Y#, Shen W, Liu DP*, Liu G, Wang Z, Tang XB, Liang CC. Cluster specific regulation pattern of upstream regulatory elements in human α- and β-globin gene clusters. Exp. Cell Res. 2008, 314(1):115-22

85.    Wei YJ#*, Tang Y#, Cui CJ#, Zhang H, Liu XN, Zhang H, Hu SS*. Expression pattern of dog stromal cell derived factor-1 (SDF-1) and implications in ischemic myocardium. Cytokine 2007, 40(1):52-9

86.    Tang Y, Wang Z, Huang Y, Liu G, Shen W, Tang XB, Feng DX, Liu DP*, Liang CC, Gene Order in Human alpha-globin Locus is Required for Their Temporal Specific Expressions. Genes Cells. 2006,11(2):123-31.

87.    Tang Y, Liu DP*, Liang CC. Further understanding of the beta-globin locus regulation at the molecular level: looping or linking models? Genes Cells. 2002, 7(9): 889-900.

88.    Tang XB, Feng DX, Di LJ, Huang Y, Fu XH, Liu G, Tang Y, Liu DP*, Liang CC. HS-48 alone has no enhancement role on the expression of human alpha-globin gene cluster. Blood Cells Mol Dis. 2007, 38(1):32-6

89.    Shen W, Huang Y, Tang Y, Liu DP*, Liang CC. A General Method to Modify BACs to Generate Large Recombinant DNA Fragments Mol. Biotechnology.2005, 31: 181-186

90.    Huang Y, Liu DP*, Feng DX, Wu M, Shen W, Tang Y, Tang XB, Liang CC. No existence of translocus balancer to coordinate the expression and regulation of human hemoglobin genes in transgenic mice study. Int J Biochem Cell Biol. 2004, 36(7): 1261-5.

二、第一/通讯作者中文文章23篇

1.  中华医学会神经病学分会痴呆与认知障碍学组, 认知数字疗法中国专家共识写作组，通讯作者，认知数字疗法中国专家共识（2023）. 中华医学杂志, 2023,103(9) : 640-647.

2.   秦琪,夏心怡,唐毅.神经病学临床案例库的建立与应用研究[J].中国医刊,2023,58(02):229-232.

3.   认知训练中国指南写作组,中国医师协会神经内科医师分会,通讯作者:唐毅.认知训练中国指南(2022年版)[J].中华医学杂志,2022,102(37):2918-2925.

4.   秦琪,唐毅,曲怡达,周爱红,丁建平,尹筠思,刘勇,贾建平.利用弥散张量成像技术观察小血管病所致非痴呆型血管性认知障碍患者白质结构损害与认知下降的关系[J].首都医科大学学报,2021,42(03):373-384.

5.   邢怡，唐毅. 认知训练早期干预痴呆的研究进展[J]. 中国神经免疫学和神经病学杂志,2020,27(6):358-359.

6.   石新蕊,王治斌,唐毅.听觉信息整合障碍与阿尔茨海默病[J].中国医学前沿杂志（电子版）,2020,12(10):8-12.

7.   认知训练中国专家共识写作组, 中国医师协会神经内科医师分会认知障碍疾病专业委员会，唐毅朱祖德执笔. 认知训练中国专家共识[J].中华医学杂志,2019,99( 1 ): 4-8.

8.   中国痴呆与认知障碍诊治指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会，贾建平，唐毅执笔.2018中国痴呆与认知障碍诊治指南(六):阿尔茨海默病痴呆前阶段[J].中华医学杂志,2018,98(19):1457-1460.

9.   中国痴呆与认知障碍诊治指南写作组,中国医师协会神经内科医师分会认知障碍疾病专业委员会，唐毅，吕佩源执笔.2018中国痴呆与认知障碍诊治指南(七):阿尔茨海默病的危险因素及其干预[J].中华医学杂志,2018,98(19):1461-1466.

10.    楚长彪,唐毅. 医学专业英语运用能力培养的探索[J]. 中国医刊,2018,53(07):824-826.

11.    唐毅,杨坚炜,郭冬梅,邱琼琼,楚长彪. 免疫介导性帕金森综合征四例报告并文献复习[J]. 中国医刊,2018,53(06):665-668.

12.    唐毅. 阿尔茨海默病诊断标准：从临床诊断到病理生理诊断[J].    山东大学学报,2017,55(10):14-20.

13.    唐毅,杨坚炜,郭冬梅,李丹,赵丽娜,李洁颖,贾建平*. 皮质基底节综合征四例临床分析[J]. 中华医学杂志,2017,97(17):1343-1345.

14.    唐毅,杨坚炜,郭冬梅,楚长彪. 舞蹈病-棘红细胞增多症4例临床分析及文献复习[J]. 中国医刊,2017,52(05):81-83.

15.    唐毅,邢怡,秦伟,贾建平. 阿尔茨海默病患者性腺轴激素水平与认知功能的相关性及载脂蛋白E基因的调节作用[J]. 中华老年心脑血管病杂志,2017,19(04):340-344.

16.    唐毅,邢怡,张津等.桥本脑病患者的临床特征和预后随访观察[J].中华医学杂志,2014,94(9):670-673.

17.    唐毅,陆慧,王向波等.以周围神经损害为主要表现的汞中毒患者9例分析[J].疑难病杂志,2014,13(2):139-142.

18.    唐毅,楚长彪.医学英语教学的特点分析和策略探讨[J].中国医药导报,2014,11(4):122-124.

19.    唐毅,王向波.小柳原田病合并脊髓损害的临床研究并文献复习[J].中国医刊,2014,49(1):44-46.

20.    唐毅,纪笑娟,邢怡，左秀美, 周爱红, 贾建平*.帕金森病痴呆与阿尔茨海默病的认知和精神行为症状比较[J].中华医学杂志,2013,93(31):2459-2462.

21.    唐毅,贾建平. tau蛋白和自噬在PS-1基因突变发病机制中的作用[J]. 中国现代神经疾病杂志,2010,02:261-264.

22.    唐毅,贾建平. 肌张力障碍的治疗进展[J].中风与神经疾病杂志,2007,05:629-632.

23.    唐毅,魏英杰,胡盛寿等.SDF-1-CXCR4轴与缺血性心脏病的干细胞治疗[J].基础医学与临床,2006,26(8):915-921.